MEDICAL ADVISORY BOARD
It is explicitly highlighted that the members of our Medical Advisory Board provide advice to MC Sciences on a voluntary basis without any compensation, any ownership in MC Sciences and without any financial advantages from supporting MC Sciences. The aim of our Medical Advisory Board is to advise and support so that patients in urgent need for new therapies can benefit from our novel therapy options. Currently no clinical trials or studies are being conducted or have been started.
Lawrence B. Afrin, M.D.
Senior Consultant in Hematology/Oncology, World-wide Leading Expert in Mast Cell Activation Syndrome, Armonk Integrative Medicine
Dr. Afrin is an internationally recognized leading expert in mast cell diseases, especially mast cell activation syndrome. He has an extensive record of peer-reviewed publications, including some of the most highly accessed articles about mast cell activation diseases as well as being the author of the highly recognized book: Never Bet Against Occam: Mast Cell Activation Disease and the Modern Epidemics of Chronic Illness and Medical Complexity. In the past decade, Dr. Afrin has significantly contributed to establishing internationally recognized practices and guidelines for diagnosing and treating mast cell disease.
Dr. Afrin has served on multiple medical advisory boards for various organizations in the field of mast cell diseases, and serves on the editorial boards for several journals. He has also served on national panels on oncology education and quality care and has spoken widely in his areas of focus.
Dr. Afrin earned a B.S. in Computer Science at Clemson University and then an M.D. at the Medical University of South Carolina (MUSC), where he then also pursued internal medicine residency and hematology and oncology clinical and research fellowships. While on faculty at MUSC 1995-2014, he was active in undergraduate and graduate medical education, information technology and educational administration (including hematology/oncology fellowship program director for 13 years), and research in hematology/oncology and medical informatics.
Since the mid-2000s, Dr. Afrin’s clinical work has increasingly focused in hematology, especially mast cell diseases. He directed MUSC’s hematology/oncology fellowship training program and myeloproliferative neoplasms clinical trials program. While at the University of Minnesota from 2014 to 2017, he increasingly focused his clinical practice in mast cell diseases and also served as assistant hematology/oncology fellowship program director, hematology/oncology medical student education director, and IRB reviewer. In 2017, he left the University of Minnesota to develop an independent institute (located in the greater New York City area) for advancing care, research, and education in mast cell disease, and he is working to develop a global investigative network in the area of mast cell disease.
Prof. Dr. Jürgen Homann
Associate Professor of Internal Medicine, Gastroenterology
Prof. Dr. Homann is an expert in internal medicine, in particular ,in mast cell diseases, hepatology and toxicology and has an extensive track record of international well-known publications and is recognized as a leading medical practitioner and researcher in the area of mast cell systems and diseases.
Prof. Dr. Homann served as head of the department of internal medicine at the Evangelische Waldkrankenhaus in Bonn Bad Godesberg for 20 years before joining the Gemeinschaftskrankenhaus Bonn as Associate Professor as part of the academic staff. For more than 20 years Prof. Dr. Homann gained in-depth practical experience in treating patients with mast cell related diseases and significantly supported establishing now standard diagnostic and therapeutic treatment guidelines for mast cell related diseases.
Before becoming the head of the department of internal medicine, Prof. Dr. Homann gained 15 years of extensive medical and research experience as associate professor of internal medicine at the center for internal medicine Giessen. Prof. Dr. Homann majored in human medicine at the Justus-Liebig-University Giessen receiving his doctoral degree (M.D.) and licence to practice medicine.
Leonard B. Weinstock, M.D., F.A.C.G.
Associate Professor of Clinical Medicine and Surgery at Washington University School of Medicine, Worldwide Leading Expert in Mast Cell Diseases related to Gastroenterology
Dr. Leonard B. Weinstock is Board Certified in Gastroenterology and Internal Medicine and is president of Specialists in Gastroenterology and the Advanced Endoscopy Center. Further Prof. Weinstock is an Associate Professor of Clinical Medicine and Surgery at Washington University School of Medicine and a primary investigator at the Sundance Research Center.
Dr. Weinstock is an international recognized leading expert in mast cell-related gastroenterological diseases. He is an active lecturer and has an extensive record of more than 100 published articles, abstracts, editorials and book chapters. Prof. Weinstock is intensively researching the role of mast cell activation in gastroenterological diseases, small intestinal bacterial overgrowth, restless legs syndrome, and rosacea.
Dr. Weinstock has extensive expertise with low dose naltrexone (LDN) in multiple inflammatory and autoimmune conditions. In the past decade, he has significantly contributed to establishing internationally recognized practices and guidelines for diagnosing and treating mast cell-related gastroenterological diseases.
Dr. Weinstock received a BA Magna Cum Laude from University of Vermont and the medical degree from University of Rochester School of Medicine. He completed his postgraduate training and was chief resident in Internal Medicine at Rochester General Hospital. His Gastroenterology Fellowship was performed at Washington University School of Medicine.